Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial.
暂无分享,去创建一个
C. Held | S. Mehta | R. Harrington | P. Steg | T. Simon | L. Leiter | D. Bhatt | J. Abtan | K. Fox | Qi Gao
[1] Deepak L. Bhatt,et al. THEMIS and THEMIS-PCI. , 2019, European heart journal.
[2] Deepak L. Bhatt,et al. Ticagrelor in Patients with Stable Coronary Disease and Diabetes. , 2019, The New England journal of medicine.
[3] Deepak L. Bhatt,et al. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. , 2019, Lancet.
[4] Deepak L. Bhatt,et al. Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study , 2019, Clinical cardiology.
[5] J. Alpert,et al. Fourth universal definition of myocardial infarction (2018). , 2019, Revista espanola de cardiologia.